Evolving Perspectives in Psychosurgery: A Comprehensive Analysis from Lobotomy to Connectomics - Scorecard - MDSpire

Evolving Perspectives in Psychosurgery: A Comprehensive Analysis from Lobotomy to Connectomics

  • By

  • Victor González

  • Jordi Rumià

  • Marta Brell

  • Carolina Roset

  • José de Miguel

  • Susana Arboleya

  • Iratxe Aguirre

  • Daniel Alegre

  • Victor Goliney

  • Javier Ibáñez

  • April 23, 2026

  • 0 min

Share

Clinical Scorecard: Evolving Perspectives in Psychosurgery: A Comprehensive Analysis from Lobotomy to Connectomics

At a Glance

CategoryDetail
ConditionSevere and treatment-resistant psychiatric disorders
Key MechanismsCircuit-based medicine focusing on fronto-limbic networks and connectomics
Target PopulationCarefully selected subgroups of treatment-refractory patients
Care SettingMultimodal approach including neurosurgery, psychotherapy, and psychosocial rehabilitation

Key Highlights

  • Shift from broad lesions to targeted interventions within brain circuits
  • Integration of modern imaging techniques for precise targeting
  • Emphasis on symptom dimensions over categorical diagnoses
  • Use of both ablative and stimulation-based interventions
  • Focus on ethical and organizational challenges in psychosurgery

Guideline-Based Recommendations

Diagnosis

  • Focus on symptom clusters rather than DSM categorical diagnoses

Management

  • Utilize a multimodal approach including candidate selection and interdisciplinary discussion

Monitoring & Follow-up

  • Long-term follow-up with device programming and psychosocial rehabilitation

Risks

  • Consideration of ethical implications and potential stigma associated with psychosurgery

Patient & Prescribing Data

Patients with severe and persistent psychiatric disorders, particularly those with treatment-resistant symptoms

Ablative procedures and deep brain stimulation are clinically meaningful interventions

Clinical Best Practices

  • Employ connectivity-based planning for surgical interventions
  • Integrate psychotherapeutic and pharmacological strategies with neuromodulation
  • Prioritize evidence from landmark trials and high-quality observational studies

References

Original Source(s)

Related Content